 Peter Buttrick
Concepts (571)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 55 | 2018 | 1002 | 3.570 |
Why?
| | Heart Ventricles | 20 | 2023 | 792 | 2.180 |
Why?
| | Myocardial Contraction | 23 | 2011 | 340 | 1.940 |
Why?
| | Protein Kinase C | 20 | 2014 | 260 | 1.920 |
Why?
| | Heart Failure | 21 | 2023 | 2228 | 1.890 |
Why?
| | Cardiomegaly | 21 | 2013 | 175 | 1.790 |
Why?
| | Ventricular Dysfunction, Right | 7 | 2023 | 236 | 1.630 |
Why?
| | Myocytes, Cardiac | 14 | 2022 | 528 | 1.490 |
Why?
| | Troponin I | 10 | 2013 | 84 | 1.250 |
Why?
| | Isoenzymes | 18 | 2002 | 304 | 1.200 |
Why?
| | Heart | 22 | 2022 | 656 | 1.080 |
Why?
| | Actin Cytoskeleton | 7 | 2011 | 100 | 0.930 |
Why?
| | Ventricular Function, Right | 6 | 2023 | 283 | 0.880 |
Why?
| | Muscle Proteins | 5 | 2025 | 229 | 0.860 |
Why?
| | Ventricular Remodeling | 9 | 2025 | 262 | 0.850 |
Why?
| | Cardiomyopathy, Dilated | 7 | 2025 | 383 | 0.840 |
Why?
| | Myosins | 18 | 2018 | 132 | 0.800 |
Why?
| | Ventricular Function, Left | 6 | 2025 | 540 | 0.740 |
Why?
| | Phosphorylation | 19 | 2016 | 1756 | 0.730 |
Why?
| | Heart-Assist Devices | 3 | 2012 | 552 | 0.720 |
Why?
| | Hypertension, Pulmonary | 8 | 2023 | 1902 | 0.650 |
Why?
| | Protein Kinase C-epsilon | 9 | 2007 | 25 | 0.650 |
Why?
| | Myosin Light Chains | 4 | 2013 | 26 | 0.630 |
Why?
| | Stroke Volume | 10 | 2025 | 619 | 0.630 |
Why?
| | Scientific Misconduct | 1 | 2019 | 12 | 0.620 |
Why?
| | Rats | 50 | 2013 | 5628 | 0.620 |
Why?
| | Carrier Proteins | 5 | 2022 | 768 | 0.610 |
Why?
| | Myocardial Infarction | 9 | 2013 | 1045 | 0.590 |
Why?
| | Sarcomeres | 7 | 2021 | 95 | 0.590 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 5 | 2011 | 135 | 0.580 |
Why?
| | Physical Conditioning, Animal | 8 | 2006 | 255 | 0.570 |
Why?
| | Neprilysin | 1 | 2018 | 47 | 0.560 |
Why?
| | Animals | 88 | 2023 | 36768 | 0.540 |
Why?
| | Editorial Policies | 1 | 2017 | 51 | 0.500 |
Why?
| | Gene Expression Regulation | 9 | 2019 | 2603 | 0.490 |
Why?
| | Cardiac Myosins | 2 | 2013 | 30 | 0.490 |
Why?
| | Calcium | 11 | 2011 | 1197 | 0.490 |
Why?
| | Myocardial Ischemia | 4 | 2019 | 263 | 0.480 |
Why?
| | Rats, Wistar | 17 | 2006 | 454 | 0.480 |
Why?
| | Adrenergic beta-Agonists | 5 | 2002 | 133 | 0.470 |
Why?
| | Histone Deacetylases | 2 | 2013 | 214 | 0.440 |
Why?
| | Periodicals as Topic | 1 | 2017 | 210 | 0.440 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1043 | 0.430 |
Why?
| | Serine | 3 | 2013 | 141 | 0.430 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2021 | 277 | 0.430 |
Why?
| | Apoptosis | 5 | 2002 | 2548 | 0.420 |
Why?
| | Aortic Valve Stenosis | 2 | 2013 | 229 | 0.410 |
Why?
| | Valproic Acid | 1 | 2013 | 47 | 0.410 |
Why?
| | Hydroxamic Acids | 1 | 2013 | 89 | 0.400 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 389 | 0.390 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2002 | 313 | 0.370 |
Why?
| | Gene Expression | 14 | 2017 | 1499 | 0.370 |
Why?
| | Isoproterenol | 6 | 2004 | 113 | 0.370 |
Why?
| | Recovery of Function | 3 | 2011 | 655 | 0.370 |
Why?
| | Models, Biological | 3 | 2021 | 1769 | 0.340 |
Why?
| | RNA, Messenger | 15 | 2017 | 2831 | 0.340 |
Why?
| | Heart Rate | 9 | 2025 | 823 | 0.330 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2025 | 323 | 0.330 |
Why?
| | Dobutamine | 5 | 2005 | 39 | 0.310 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2021 | 250 | 0.310 |
Why?
| | Receptors, Adrenergic, beta | 3 | 2011 | 127 | 0.300 |
Why?
| | Mice | 27 | 2022 | 17731 | 0.300 |
Why?
| | Phenotype | 3 | 2025 | 3199 | 0.300 |
Why?
| | Angiotensin Receptor Antagonists | 3 | 1997 | 92 | 0.290 |
Why?
| | Phosphoserine | 2 | 2007 | 34 | 0.280 |
Why?
| | Cattle | 6 | 2023 | 981 | 0.280 |
Why?
| | Humans | 53 | 2025 | 136783 | 0.280 |
Why?
| | Disease Models, Animal | 11 | 2023 | 4279 | 0.280 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2023 | 145 | 0.280 |
Why?
| | Catecholamines | 5 | 2022 | 98 | 0.270 |
Why?
| | Protein Processing, Post-Translational | 5 | 2016 | 467 | 0.270 |
Why?
| | Enzyme Inhibitors | 6 | 2002 | 838 | 0.270 |
Why?
| | Muscle Strength | 1 | 2010 | 317 | 0.270 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 201 | 0.260 |
Why?
| | Tissue and Organ Procurement | 1 | 2010 | 314 | 0.260 |
Why?
| | Pharmacogenetics | 1 | 2008 | 179 | 0.260 |
Why?
| | Biophysics | 1 | 2007 | 69 | 0.260 |
Why?
| | NAD | 1 | 2007 | 77 | 0.260 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2006 | 72 | 0.250 |
Why?
| | Mitochondria, Heart | 1 | 2007 | 100 | 0.250 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2006 | 73 | 0.250 |
Why?
| | Cytosol | 1 | 2007 | 226 | 0.250 |
Why?
| | Glycolysis | 2 | 2012 | 318 | 0.250 |
Why?
| | Mice, Transgenic | 13 | 2018 | 2162 | 0.250 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 480 | 0.240 |
Why?
| | Signal Transduction | 10 | 2021 | 5065 | 0.240 |
Why?
| | Models, Animal | 1 | 2007 | 384 | 0.230 |
Why?
| | Hypertension, Renovascular | 3 | 1994 | 15 | 0.230 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 657 | 0.230 |
Why?
| | Hypertension | 5 | 2007 | 1284 | 0.230 |
Why?
| | Myosin Heavy Chains | 3 | 2004 | 191 | 0.230 |
Why?
| | Fibroblasts | 4 | 2020 | 989 | 0.230 |
Why?
| | Renin-Angiotensin System | 2 | 1996 | 84 | 0.220 |
Why?
| | Male | 39 | 2025 | 67361 | 0.220 |
Why?
| | Calcineurin | 2 | 2002 | 108 | 0.220 |
Why?
| | MAP Kinase Signaling System | 1 | 2006 | 321 | 0.220 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 925 | 0.220 |
Why?
| | Angiotensin II | 2 | 2001 | 99 | 0.210 |
Why?
| | Gene Transfer Techniques | 3 | 2000 | 169 | 0.210 |
Why?
| | GATA4 Transcription Factor | 2 | 2020 | 18 | 0.210 |
Why?
| | Female | 49 | 2025 | 72840 | 0.200 |
Why?
| | Chronic Disease | 2 | 2020 | 1784 | 0.200 |
Why?
| | Collagen | 3 | 2016 | 445 | 0.200 |
Why?
| | Thromboxane A2 | 2 | 2002 | 11 | 0.190 |
Why?
| | Cardiovascular Diseases | 3 | 2007 | 2108 | 0.190 |
Why?
| | Hemodynamics | 9 | 2011 | 1110 | 0.190 |
Why?
| | Cardiac Output, Low | 1 | 2002 | 66 | 0.190 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2001 | 22 | 0.190 |
Why?
| | Dilatation, Pathologic | 1 | 2001 | 61 | 0.190 |
Why?
| | Rats, Inbred Strains | 14 | 1992 | 361 | 0.180 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 646 | 0.180 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2002 | 98 | 0.180 |
Why?
| | Heart Diseases | 2 | 2019 | 359 | 0.180 |
Why?
| | Genetic Therapy | 3 | 2000 | 296 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2021 | 856 | 0.180 |
Why?
| | Calcium Signaling | 3 | 2011 | 249 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2004 | 193 | 0.180 |
Why?
| | Organ Size | 12 | 2001 | 477 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 973 | 0.170 |
Why?
| | Brachial Artery | 1 | 2002 | 201 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 62 | 0.170 |
Why?
| | Cyclosporine | 1 | 2001 | 268 | 0.170 |
Why?
| | Biomedical Research | 1 | 2007 | 689 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2022 | 227 | 0.170 |
Why?
| | Adaptation, Physiological | 4 | 2012 | 546 | 0.170 |
Why?
| | Tetrazoles | 2 | 1997 | 40 | 0.160 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 181 | 0.160 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2002 | 227 | 0.160 |
Why?
| | Molecular Sequence Data | 8 | 2012 | 2903 | 0.160 |
Why?
| | Blood Pressure | 11 | 2012 | 1772 | 0.160 |
Why?
| | Cardiotonic Agents | 3 | 2005 | 125 | 0.160 |
Why?
| | Animals, Newborn | 5 | 2011 | 843 | 0.160 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2021 | 142 | 0.160 |
Why?
| | Cell Dedifferentiation | 1 | 2019 | 32 | 0.160 |
Why?
| | Phototherapy | 1 | 2019 | 37 | 0.160 |
Why?
| | Cells, Cultured | 13 | 2021 | 4194 | 0.160 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 30 | 0.150 |
Why?
| | Autophagosomes | 1 | 2018 | 19 | 0.150 |
Why?
| | Cocaine | 2 | 1991 | 165 | 0.150 |
Why?
| | Circadian Clocks | 1 | 2019 | 50 | 0.150 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2018 | 25 | 0.150 |
Why?
| | Body Weight | 10 | 2001 | 981 | 0.150 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 241 | 0.150 |
Why?
| | Membrane Fusion | 1 | 2018 | 39 | 0.150 |
Why?
| | Imidazoles | 2 | 1997 | 239 | 0.150 |
Why?
| | In Vitro Techniques | 8 | 2011 | 1089 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 363 | 0.150 |
Why?
| | Hyperglycemia | 1 | 2002 | 346 | 0.150 |
Why?
| | Amphiregulin | 1 | 2018 | 25 | 0.140 |
Why?
| | Lysosomes | 1 | 2018 | 142 | 0.140 |
Why?
| | Systole | 3 | 2005 | 191 | 0.140 |
Why?
| | Adenosine Triphosphatases | 5 | 2005 | 165 | 0.140 |
Why?
| | Transfection | 4 | 2002 | 945 | 0.140 |
Why?
| | Echocardiography | 3 | 2009 | 659 | 0.140 |
Why?
| | Receptors, Histamine H2 | 1 | 2017 | 8 | 0.140 |
Why?
| | Filamins | 1 | 2018 | 28 | 0.140 |
Why?
| | In Situ Nick-End Labeling | 3 | 2002 | 124 | 0.140 |
Why?
| | Physical Exertion | 3 | 1988 | 215 | 0.140 |
Why?
| | Period Circadian Proteins | 2 | 2019 | 16 | 0.140 |
Why?
| | Actomyosin | 1 | 1997 | 18 | 0.140 |
Why?
| | Aging | 5 | 2008 | 1861 | 0.140 |
Why?
| | Enzyme Activation | 4 | 2002 | 813 | 0.130 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2018 | 134 | 0.130 |
Why?
| | Protein Kinase C beta | 6 | 2008 | 21 | 0.130 |
Why?
| | Coronary Circulation | 4 | 2004 | 141 | 0.130 |
Why?
| | Myofibrils | 2 | 2021 | 49 | 0.130 |
Why?
| | Angiotensin I | 1 | 1996 | 7 | 0.130 |
Why?
| | Patient Participation | 1 | 2020 | 416 | 0.130 |
Why?
| | Activities of Daily Living | 1 | 2020 | 412 | 0.130 |
Why?
| | Sex Characteristics | 3 | 2006 | 763 | 0.130 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 5744 | 0.130 |
Why?
| | Middle Aged | 12 | 2025 | 33200 | 0.120 |
Why?
| | Hypoxia | 4 | 2023 | 1107 | 0.120 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2015 | 11 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1996 | 185 | 0.120 |
Why?
| | Amino Acid Substitution | 2 | 2007 | 309 | 0.120 |
Why?
| | Ultrasonography | 2 | 2012 | 751 | 0.120 |
Why?
| | Coronary Artery Disease | 1 | 2002 | 702 | 0.120 |
Why?
| | Time Factors | 8 | 2009 | 6792 | 0.120 |
Why?
| | rho-Associated Kinases | 1 | 2015 | 83 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2015 | 98 | 0.110 |
Why?
| | Coronary Vessels | 2 | 1987 | 245 | 0.110 |
Why?
| | Blotting, Western | 2 | 2015 | 1225 | 0.110 |
Why?
| | Heart Transplantation | 4 | 2011 | 747 | 0.110 |
Why?
| | Atrial Natriuretic Factor | 2 | 2007 | 56 | 0.110 |
Why?
| | Tetracycline | 1 | 1994 | 13 | 0.110 |
Why?
| | Interleukin-18 | 1 | 2016 | 237 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1453 | 0.110 |
Why?
| | Amino Acid Sequence | 4 | 2012 | 2145 | 0.110 |
Why?
| | Renin | 1 | 1993 | 34 | 0.100 |
Why?
| | Cardiac Output | 3 | 2012 | 164 | 0.100 |
Why?
| | Sodium, Dietary | 1 | 1993 | 41 | 0.100 |
Why?
| | Protein Phosphatase 1 | 1 | 2013 | 33 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 1980 | 0.100 |
Why?
| | Protein Phosphatase 2 | 1 | 2013 | 41 | 0.100 |
Why?
| | Antibodies | 2 | 2013 | 412 | 0.100 |
Why?
| | Immunohistochemistry | 4 | 2018 | 1731 | 0.100 |
Why?
| | Cell Line | 6 | 2021 | 2836 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 1996 | 488 | 0.100 |
Why?
| | Protein Disulfide-Isomerases | 1 | 2012 | 11 | 0.100 |
Why?
| | Contractile Proteins | 5 | 1996 | 15 | 0.100 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2005 | 216 | 0.100 |
Why?
| | Substance-Related Disorders | 2 | 1991 | 1072 | 0.090 |
Why?
| | Receptor, Adenosine A2B | 1 | 2012 | 43 | 0.090 |
Why?
| | Ventricular Function | 2 | 1991 | 60 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1294 | 0.090 |
Why?
| | Aorta | 2 | 2007 | 417 | 0.090 |
Why?
| | Kinetics | 4 | 2011 | 1668 | 0.090 |
Why?
| | Excitation Contraction Coupling | 1 | 2011 | 17 | 0.090 |
Why?
| | Ventricular Pressure | 1 | 2011 | 48 | 0.090 |
Why?
| | Natriuretic Peptides | 1 | 2011 | 9 | 0.090 |
Why?
| | Hyperbaric Oxygenation | 1 | 2011 | 39 | 0.090 |
Why?
| | Disease Progression | 3 | 2009 | 2750 | 0.090 |
Why?
| | Desmin | 1 | 2010 | 24 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 1991 | 60 | 0.090 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 82 | 0.090 |
Why?
| | Peptide Fragments | 2 | 2007 | 707 | 0.090 |
Why?
| | Epoprostenol | 3 | 1986 | 136 | 0.090 |
Why?
| | Chest Pain | 1 | 1990 | 91 | 0.080 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 86 | 0.080 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 114 | 0.080 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2012 | 210 | 0.080 |
Why?
| | Cyclic AMP | 3 | 2008 | 234 | 0.080 |
Why?
| | Promoter Regions, Genetic | 6 | 1994 | 1250 | 0.080 |
Why?
| | Cardiovascular Physiological Phenomena | 2 | 2006 | 42 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 5 | 2012 | 2481 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2011 | 152 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2002 | 436 | 0.080 |
Why?
| | Biopsy | 1 | 2013 | 1126 | 0.080 |
Why?
| | Reactive Oxygen Species | 2 | 2002 | 618 | 0.080 |
Why?
| | Blotting, Northern | 2 | 2001 | 199 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2012 | 444 | 0.080 |
Why?
| | Aged | 9 | 2025 | 23729 | 0.080 |
Why?
| | Platelet Aggregation | 3 | 1986 | 100 | 0.080 |
Why?
| | Energy Metabolism | 3 | 2007 | 918 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2011 | 324 | 0.080 |
Why?
| | Sex Factors | 2 | 2013 | 2068 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2022 | 2999 | 0.070 |
Why?
| | MicroRNAs | 2 | 2015 | 697 | 0.070 |
Why?
| | Toxicogenetics | 1 | 2008 | 6 | 0.070 |
Why?
| | Cell Hypoxia | 2 | 2019 | 225 | 0.070 |
Why?
| | Digoxin | 1 | 2008 | 30 | 0.070 |
Why?
| | Biological Transport | 2 | 2002 | 411 | 0.070 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 28 | 0.070 |
Why?
| | Adult | 11 | 2020 | 37616 | 0.070 |
Why?
| | Mitochondria | 1 | 2014 | 946 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 591 | 0.070 |
Why?
| | Mutation | 2 | 2018 | 3953 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2002 | 284 | 0.070 |
Why?
| | Embryo, Mammalian | 2 | 2020 | 231 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2007 | 616 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 2 | 2022 | 331 | 0.070 |
Why?
| | Consensus Sequence | 1 | 2007 | 73 | 0.070 |
Why?
| | RNA | 2 | 2006 | 924 | 0.070 |
Why?
| | Base Sequence | 5 | 1994 | 2180 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2001 | 2045 | 0.070 |
Why?
| | Biophysical Phenomena | 1 | 2007 | 64 | 0.070 |
Why?
| | Ligation | 1 | 2007 | 87 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 532 | 0.070 |
Why?
| | Clinical Medicine | 1 | 2007 | 24 | 0.070 |
Why?
| | Protein Conformation | 1 | 2010 | 940 | 0.070 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2007 | 46 | 0.070 |
Why?
| | Pregnancy, Animal | 1 | 1987 | 52 | 0.070 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 19 | 0.070 |
Why?
| | Thyroid Hormones | 3 | 1993 | 61 | 0.060 |
Why?
| | Chloramphenicol O-Acetyltransferase | 4 | 1994 | 38 | 0.060 |
Why?
| | Nitroimidazoles | 1 | 2006 | 9 | 0.060 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2007 | 128 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2006 | 29 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2007 | 1062 | 0.060 |
Why?
| | Butyrates | 1 | 2007 | 61 | 0.060 |
Why?
| | Fibrosis | 2 | 2015 | 551 | 0.060 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2006 | 68 | 0.060 |
Why?
| | Heat-Shock Proteins | 1 | 2006 | 142 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 451 | 0.060 |
Why?
| | DNA-Binding Proteins | 2 | 2006 | 1500 | 0.060 |
Why?
| | Heart Atria | 1 | 1986 | 136 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2012 | 15564 | 0.060 |
Why?
| | Swimming | 5 | 1990 | 49 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2013 | 3537 | 0.060 |
Why?
| | Age Factors | 3 | 2008 | 3290 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2847 | 0.060 |
Why?
| | Transcription Factors | 2 | 2006 | 1714 | 0.060 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 35 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1997 | 534 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 345 | 0.060 |
Why?
| | Phenylephrine | 2 | 2021 | 75 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2004 | 90 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2007 | 256 | 0.060 |
Why?
| | Osteopontin | 1 | 2004 | 33 | 0.060 |
Why?
| | Animals, Genetically Modified | 1 | 2005 | 240 | 0.060 |
Why?
| | Protein Kinase C-delta | 2 | 2002 | 48 | 0.060 |
Why?
| | Potassium Channels | 1 | 2025 | 150 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2012 | 2473 | 0.050 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 159 | 0.050 |
Why?
| | Ventricular Myosins | 1 | 2004 | 35 | 0.050 |
Why?
| | Drug Resistance | 1 | 2004 | 169 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2025 | 10764 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 160 | 0.050 |
Why?
| | Anticoagulants | 1 | 2008 | 658 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 663 | 0.050 |
Why?
| | Up-Regulation | 2 | 2007 | 843 | 0.050 |
Why?
| | Rats, Inbred F344 | 4 | 1997 | 264 | 0.050 |
Why?
| | Mutagenesis | 1 | 2004 | 182 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2831 | 0.050 |
Why?
| | Calcium-Transporting ATPases | 3 | 1993 | 40 | 0.050 |
Why?
| | Cytokines | 1 | 2011 | 2088 | 0.050 |
Why?
| | Exercise Therapy | 1 | 1987 | 434 | 0.050 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2002 | 26 | 0.050 |
Why?
| | Mannitol | 1 | 2002 | 38 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 53 | 0.050 |
Why?
| | Osmolar Concentration | 1 | 2002 | 170 | 0.050 |
Why?
| | Massachusetts | 1 | 2022 | 170 | 0.050 |
Why?
| | Chromones | 1 | 2002 | 44 | 0.050 |
Why?
| | Hydroxyproline | 1 | 2001 | 21 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 110 | 0.050 |
Why?
| | Pulsatile Flow | 1 | 2002 | 60 | 0.050 |
Why?
| | GTP-Binding Proteins | 1 | 2002 | 161 | 0.050 |
Why?
| | Muscles | 3 | 1994 | 325 | 0.050 |
Why?
| | Androstadienes | 1 | 2002 | 107 | 0.050 |
Why?
| | Lac Operon | 1 | 2001 | 44 | 0.040 |
Why?
| | United States | 3 | 2022 | 14660 | 0.040 |
Why?
| | Flavonoids | 1 | 2001 | 83 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 317 | 0.040 |
Why?
| | Hypertrophy | 1 | 2001 | 132 | 0.040 |
Why?
| | beta-Galactosidase | 1 | 2001 | 77 | 0.040 |
Why?
| | Morpholines | 1 | 2002 | 121 | 0.040 |
Why?
| | Proline | 1 | 2001 | 79 | 0.040 |
Why?
| | Glucose | 2 | 2007 | 1019 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 307 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2002 | 384 | 0.040 |
Why?
| | Models, Chemical | 1 | 2002 | 268 | 0.040 |
Why?
| | Calcium Channels, L-Type | 1 | 2002 | 118 | 0.040 |
Why?
| | American Heart Association | 1 | 2022 | 306 | 0.040 |
Why?
| | Sarcoplasmic Reticulum | 2 | 1993 | 46 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2022 | 400 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 167 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 34 | 0.040 |
Why?
| | Protein Kinases | 1 | 2002 | 319 | 0.040 |
Why?
| | Cardiac Pacing, Artificial | 3 | 1998 | 87 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1981 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2018 | 2190 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 393 | 0.040 |
Why?
| | Protein Transport | 1 | 2001 | 442 | 0.040 |
Why?
| | Carotid Arteries | 1 | 2001 | 209 | 0.040 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 1999 | 19 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 1999 | 49 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 455 | 0.040 |
Why?
| | Organ Culture Techniques | 2 | 2007 | 155 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2018 | 19 | 0.040 |
Why?
| | Qa-SNARE Proteins | 1 | 2018 | 20 | 0.040 |
Why?
| | Biomechanical Phenomena | 2 | 1996 | 808 | 0.040 |
Why?
| | Action Potentials | 2 | 2015 | 495 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2018 | 46 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.040 |
Why?
| | Cell Membrane | 1 | 2002 | 736 | 0.040 |
Why?
| | Tachycardia | 1 | 1998 | 58 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 115 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 434 | 0.040 |
Why?
| | Hypertension, Renal | 2 | 1989 | 16 | 0.040 |
Why?
| | Cell Survival | 1 | 2001 | 1117 | 0.040 |
Why?
| | Streptozocin | 1 | 1997 | 20 | 0.040 |
Why?
| | Blood Platelets | 3 | 1986 | 405 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2018 | 116 | 0.040 |
Why?
| | Prazosin | 1 | 1997 | 23 | 0.040 |
Why?
| | Death, Sudden | 1 | 1997 | 24 | 0.040 |
Why?
| | Epinephrine | 3 | 1988 | 139 | 0.040 |
Why?
| | Adrenergic alpha-Agonists | 1 | 1997 | 28 | 0.040 |
Why?
| | Electrocardiography | 2 | 1991 | 628 | 0.040 |
Why?
| | Fatty Acids | 1 | 2021 | 444 | 0.040 |
Why?
| | Research Design | 2 | 2022 | 1107 | 0.030 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 1998 | 130 | 0.030 |
Why?
| | Pharmacogenomic Variants | 1 | 2017 | 35 | 0.030 |
Why?
| | Protein Biosynthesis | 2 | 1997 | 433 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2023 | 778 | 0.030 |
Why?
| | Threonine | 1 | 1997 | 46 | 0.030 |
Why?
| | Adenosine Triphosphate | 3 | 2011 | 486 | 0.030 |
Why?
| | Diastole | 2 | 1988 | 150 | 0.030 |
Why?
| | Integrases | 1 | 2018 | 120 | 0.030 |
Why?
| | Models, Molecular | 1 | 2002 | 1591 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2012 | 474 | 0.030 |
Why?
| | Europe | 1 | 2018 | 414 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 400 | 0.030 |
Why?
| | Alanine | 1 | 1997 | 151 | 0.030 |
Why?
| | Biomarkers | 2 | 2013 | 4158 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 467 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1997 | 376 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 234 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1108 | 0.030 |
Why?
| | Dogs | 1 | 1997 | 409 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 1993 | 92 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 544 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2016 | 80 | 0.030 |
Why?
| | MEF2 Transcription Factors | 1 | 2015 | 61 | 0.030 |
Why?
| | Peptides | 1 | 2001 | 980 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 621 | 0.030 |
Why?
| | DNA Methylation | 1 | 2020 | 644 | 0.030 |
Why?
| | Creatine Kinase | 2 | 1997 | 79 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 138 | 0.030 |
Why?
| | Histones | 1 | 2020 | 635 | 0.030 |
Why?
| | Phosphofructokinase-1 | 1 | 2014 | 7 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 170 | 0.030 |
Why?
| | T-Box Domain Proteins | 1 | 2015 | 98 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 1994 | 51 | 0.030 |
Why?
| | Glucose Transporter Type 4 | 1 | 2014 | 40 | 0.030 |
Why?
| | Luciferases | 2 | 1992 | 150 | 0.030 |
Why?
| | Antibody Specificity | 2 | 2013 | 189 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2014 | 41 | 0.030 |
Why?
| | Troponin | 1 | 1994 | 51 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 343 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 1994 | 49 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1455 | 0.030 |
Why?
| | Cytochalasin B | 1 | 1974 | 17 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1974 | 42 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1260 | 0.030 |
Why?
| | Oxygen Consumption | 3 | 1997 | 696 | 0.030 |
Why?
| | Connexin 43 | 1 | 1994 | 31 | 0.030 |
Why?
| | Adenoviridae | 1 | 1994 | 193 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 182 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1768 | 0.030 |
Why?
| | Norepinephrine | 3 | 1992 | 204 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 1997 | 1354 | 0.030 |
Why?
| | Thyroxine | 1 | 1994 | 62 | 0.030 |
Why?
| | Cytomegalovirus | 1 | 1993 | 157 | 0.020 |
Why?
| | Erythrocytes | 2 | 1977 | 692 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2012 | 28 | 0.020 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 38 | 0.020 |
Why?
| | Avian Sarcoma Viruses | 1 | 1992 | 4 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2012 | 57 | 0.020 |
Why?
| | Genes, Viral | 1 | 1992 | 88 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 1994 | 378 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1152 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 544 | 0.020 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1992 | 113 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2012 | 92 | 0.020 |
Why?
| | Rabbits | 3 | 1993 | 789 | 0.020 |
Why?
| | Cardioplegic Solutions | 1 | 2011 | 7 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2011 | 30 | 0.020 |
Why?
| | Buffers | 1 | 2011 | 56 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 155 | 0.020 |
Why?
| | Swine | 1 | 2013 | 773 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 217 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 2512 | 0.020 |
Why?
| | Antigen Presentation | 1 | 2012 | 215 | 0.020 |
Why?
| | Perfusion | 2 | 1997 | 211 | 0.020 |
Why?
| | New York City | 1 | 1990 | 87 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 202 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 1991 | 167 | 0.020 |
Why?
| | Education, Medical, Continuing | 1 | 1991 | 125 | 0.020 |
Why?
| | Muscle, Skeletal | 2 | 1997 | 1707 | 0.020 |
Why?
| | Growth Hormone | 1 | 1990 | 101 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 264 | 0.020 |
Why?
| | Women's Health | 1 | 1992 | 369 | 0.020 |
Why?
| | Gonadal Steroid Hormones | 1 | 1990 | 140 | 0.020 |
Why?
| | Genes | 1 | 1989 | 230 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2417 | 0.020 |
Why?
| | T-Lymphocytes | 2 | 1994 | 1998 | 0.020 |
Why?
| | Phosphocreatine | 2 | 1999 | 47 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 470 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2030 | 0.020 |
Why?
| | Injections, Subcutaneous | 1 | 1988 | 154 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 505 | 0.020 |
Why?
| | Cell Size | 1 | 2008 | 91 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2007 | 41 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2007 | 59 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2007 | 61 | 0.020 |
Why?
| | DNA | 2 | 1991 | 1458 | 0.020 |
Why?
| | Mitral Valve Stenosis | 1 | 1986 | 18 | 0.020 |
Why?
| | Risk Factors | 2 | 1991 | 10331 | 0.020 |
Why?
| | Peptide Hormones | 1 | 2006 | 11 | 0.020 |
Why?
| | Mitral Valve Insufficiency | 1 | 1986 | 69 | 0.020 |
Why?
| | Phentolamine | 1 | 1985 | 15 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3272 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2007 | 480 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7583 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7569 | 0.010 |
Why?
| | Adenosine Diphosphate | 1 | 1985 | 79 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1428 | 0.010 |
Why?
| | Actins | 1 | 1987 | 415 | 0.010 |
Why?
| | Cardiovascular System | 1 | 2006 | 139 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1986 | 372 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 2004 | 58 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 2004 | 114 | 0.010 |
Why?
| | Homeostasis | 1 | 2008 | 618 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1999 | 564 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1686 | 0.010 |
Why?
| | Motor Activity | 1 | 1988 | 719 | 0.010 |
Why?
| | Prognosis | 1 | 1991 | 4018 | 0.010 |
Why?
| | Phenanthridines | 1 | 2002 | 7 | 0.010 |
Why?
| | Benzophenanthridines | 1 | 2002 | 10 | 0.010 |
Why?
| | Papillary Muscles | 1 | 2002 | 13 | 0.010 |
Why?
| | Mesylates | 1 | 2002 | 7 | 0.010 |
Why?
| | Detergents | 1 | 2002 | 44 | 0.010 |
Why?
| | Alkaloids | 1 | 2002 | 30 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2002 | 150 | 0.010 |
Why?
| | Second Messenger Systems | 1 | 2002 | 31 | 0.010 |
Why?
| | Aspirin | 1 | 1985 | 384 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2006 | 596 | 0.010 |
Why?
| | Membrane Potentials | 1 | 2002 | 283 | 0.010 |
Why?
| | Pyrroles | 1 | 2002 | 211 | 0.010 |
Why?
| | Fetus | 2 | 1997 | 806 | 0.010 |
Why?
| | Exercise | 1 | 1992 | 2038 | 0.010 |
Why?
| | Tamoxifen | 1 | 1981 | 202 | 0.010 |
Why?
| | Phosphates | 1 | 2001 | 183 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2001 | 218 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1999 | 45 | 0.010 |
Why?
| | Early Growth Response Protein 1 | 1 | 1999 | 27 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1998 | 3 | 0.010 |
Why?
| | DNA Ligases | 1 | 1998 | 7 | 0.010 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 1998 | 12 | 0.010 |
Why?
| | Binding Sites | 1 | 2002 | 1308 | 0.010 |
Why?
| | Constriction | 1 | 1998 | 48 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1989 | 190 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 182 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 1998 | 46 | 0.010 |
Why?
| | Estrogens | 2 | 1992 | 367 | 0.010 |
Why?
| | Erythrocyte Membrane | 1 | 1977 | 55 | 0.010 |
Why?
| | Carbohydrates | 1 | 1977 | 66 | 0.010 |
Why?
| | Protein Kinase C-alpha | 1 | 1997 | 37 | 0.010 |
Why?
| | beta-Thromboglobulin | 2 | 1986 | 3 | 0.010 |
Why?
| | Thromboxane B2 | 2 | 1986 | 26 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3566 | 0.010 |
Why?
| | Running | 2 | 1988 | 230 | 0.010 |
Why?
| | RNA, Transfer, Leu | 1 | 1994 | 7 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 13126 | 0.010 |
Why?
| | Immune Adherence Reaction | 1 | 1974 | 2 | 0.010 |
Why?
| | Leucine | 1 | 1994 | 111 | 0.010 |
Why?
| | Atrophy | 1 | 1994 | 184 | 0.010 |
Why?
| | Neuraminidase | 1 | 1974 | 25 | 0.010 |
Why?
| | Vibrio cholerae | 1 | 1974 | 13 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1999 | 710 | 0.010 |
Why?
| | Intercellular Junctions | 1 | 1994 | 40 | 0.010 |
Why?
| | Pregnancy | 1 | 1987 | 6731 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1994 | 329 | 0.010 |
Why?
| | Melanoma | 1 | 1981 | 757 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 1059 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1994 | 268 | 0.010 |
Why?
| | Chick Embryo | 1 | 1993 | 130 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1994 | 198 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1981 | 852 | 0.010 |
Why?
| | Immune System | 1 | 1994 | 177 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1993 | 321 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1993 | 336 | 0.010 |
Why?
| | Denervation | 1 | 1992 | 24 | 0.010 |
Why?
| | Oxygen | 1 | 1997 | 933 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 21463 | 0.010 |
Why?
| | Triiodothyronine | 1 | 1991 | 43 | 0.010 |
Why?
| | Sheep | 1 | 1974 | 855 | 0.010 |
Why?
| | Models, Cardiovascular | 1 | 1992 | 195 | 0.010 |
Why?
| | Hypothyroidism | 1 | 1991 | 71 | 0.010 |
Why?
| | Temperature | 1 | 1974 | 674 | 0.010 |
Why?
| | Heart Valve Diseases | 1 | 1992 | 152 | 0.010 |
Why?
| | Injections | 1 | 1991 | 181 | 0.010 |
Why?
| | Orchiectomy | 1 | 1990 | 71 | 0.010 |
Why?
| | Plasmids | 1 | 1991 | 362 | 0.010 |
Why?
| | Hematocrit | 1 | 1990 | 95 | 0.010 |
Why?
| | Ovariectomy | 1 | 1990 | 151 | 0.010 |
Why?
| | DNA Probes | 1 | 1989 | 60 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1989 | 79 | 0.000 |
Why?
| | Chickens | 1 | 1989 | 191 | 0.000 |
Why?
| | Lactates | 1 | 1988 | 85 | 0.000 |
Why?
| | Testosterone | 1 | 1990 | 401 | 0.000 |
Why?
| | Lactic Acid | 1 | 1988 | 306 | 0.000 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1986 | 21 | 0.000 |
Why?
| | Child | 1 | 1986 | 21968 | 0.000 |
Why?
| | Kidney | 1 | 1993 | 1463 | 0.000 |
Why?
| | Lymphatic Metastasis | 1 | 1981 | 350 | 0.000 |
Why?
| | Hemagglutination | 1 | 1977 | 8 | 0.000 |
Why?
| | Mitogens | 1 | 1977 | 61 | 0.000 |
Why?
| | Antibody Formation | 1 | 1977 | 298 | 0.000 |
Why?
| | Lymphocytes | 1 | 1977 | 395 | 0.000 |
Why?
|
|
Buttrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|